2. ANATOMY • 2 Adrenal gland also
called suprarenal gland.
• Each adrenal gland is found in
the epigastrium at the top of
the kidney opposite the 11th
intercostal end of the
vertebral space and the 12th
rib.
• In humans each adrenal gland
weighs about 5 grams and
measures about 30 mm wide,
50 mm long, and
10 mm thick.
4. ZONA GLOMERULOSA (5%)
Cells arranged in irregular ovoid
clusters separated by delicate
fibrous trabeculae.
ZONA FASICULATA (70%)
Middle and broadest zone.
Consists of narrow columns and
cords of cells. Cell cytoplasm is
abundant and pale staining due
to large no. of lipid droplets
present.
ZONA RETICULARIS (25%)
Consists of irregular network of
branching cords and clusters of
glandular cells.
8. • Adenomas and carcinomas are about equally common in adults.
• In children, carcinomas predominate.
• Most cortical neoplasms are sporadic.
• Two familial cancer syndromes are associated with a predisposition
for developing adrenocortical carcinomas: Li-fraumeni syndrome,
germline TP53 mutations and Beckwith- wiedemann syndrome, a
disorder of epigenetic imprinting.
9. • Functional adenomas are most commonly associated with
hyperaldosteronism and Cushing syndrome
• A virilizing neoplasm is more likely to be a carcinoma.
• Functional and nonfunctional adrenocortical neoplasms cannot be
distinguished on the basis of morphologic features.
• Determination of functionality is based on clinical evaluation and
measurement of hormones or hormone metabolites in the blood.
10. Adrenal cortical adenoma
Adrenal cortical adenoma - neoplasm of adrenocortical cell derivation
that lacks morphologic features of malignancy.
ACAs may be hormonally inactive or synthesize/secrete steroid
hormones.
Most frequent hormones produced :
• Cortisol – Cushing syndrome
• Aldosterone - Primary aldosteronism
Clinically silent.
Incidental findings at autopsy or during abdominal imaging for an
unrelated cause.
11. GROSS
Well- circumscribed
Nodular lesion up to 2.5 cm in
diameter that expands the
adrenal
Functional adenomas associated
with atrophy of the adjacent
cortex
Cortex adjacent to nonfunctional
adenomas is normal.
• Cut surface
Yellow to yellow- brown because
of the presence of lipid.
13. MICROSCOPY
composed of cells similar to
those populating the normal
adrenal cortex.
Small nuclei
some degree of pleomorphism
may be seen (“endocrine
atypia”).
cytoplasm of the neoplastic
cells ranges from eosinophilic
to vacuolated, depending on
their lipid content.
Mitotic activity is generally
inconspicuous.
15. Adrenocortical Carcinoma
• Rare neoplasms
• Occur at any age, including childhood.
• More functional than adenomas
• Associated with virilism or other clinical manifestations of
hyperadrenalism.
• Strong tendency to invade the renal vein, vena cava, and lymphatics.
• Metastases to regional and periaortic nodes are common, as is distant
hematogenous spread to lungs & other visceras.
16. GROSS
Large,
Invasive lesions,
Many exceeding 20 cm in
diameter, which efface the
native adrenal gland.
• Cut surface
Variegated,
Poorly demarcated lesions
Containing areas of necrosis,
hemorrhage, and cystic
change.
17. MICROSCOPY
• composed of well-
differentiated cells,
resembling those seen in
cortical adenomas.
• Or bizarre, monstrous giant
cells which may be difficult to
distinguish from those of an
undifferentiated carcinoma
metastatic to the adrenal.
• moderate degrees of
anaplasia, some composed
predominantly of spindle
cells.
Figure 24-53 Adrenal carcinoma revealing marked anaplasia
contrasted with normal adrenal cortical cells
19. • Most important diseases of the adrenal medulla are neoplasms,
which include
Neoplasms of chromaffin cells (pheochromocytomas)
Neuronal neoplasms (neuroblastic tumors).
20. PHEOCHROMOCYTOMA
• Neoplasms composed of chromaffin cells, which synthesize and
release catecholamines and peptide hormones.
• The features of pheochromocytomas have been summarized by the
“rule of 10s”.
10 % of pheochromocytomas are extra-adrenal, occurring in sites
such as the organs of Zuckerkandl and the carotid body.
• Pheochromocytomas that develop in extra-adrenal paraganglia are
designated paragangliomas.
10 % of sporadic adrenal pheochromocytomas are bilateral.
21. 10% of adrenal pheochromocytomas are biologically malignant,
Malignancy is more common (20% to 40%) in extra- adrenal
paragangliomas and certain germline mutations.
10% of adrenal pheochromocytomas are not associated with
hypertension.
22. 25% of individuals with pheochromocytomas and paragangliomas harbor
a germline mutation in one one of at least six known genes.
23. • The affected genes fall into two broad classes, those that enhance
growth factor receptor pathway signaling (e.g., RET, NF1), and those
that increase the activity of the transcription factor HIF-1α.
• VHL gene encodes a tumor suppressor protein that is needed for the
oxygen-dependent degradation of HIF-1α and is mutated in patients
with von Hippel-Lindau (VHL) syndrome, which is associated with a
number of tumors, including pheochromocytoma.
24. • Other familial cases of pheochromocytoma are associated with
germline mutations in genes encoding components of the succinate
dehydrogenase complex (SDHB, SDHC, and SDHD).
• This complex is involved in mitochondrial electron transport and
oxygen sensing, and it is believed that these mutations also lead to
upregulation of HIF-1α, which appears to be a key oncogenic driver in
this type of tumor.
25. CLINICAL FEATURES
• Hypertension (90% of patients).
• More common: Chronic, sustained elevation in blood pressure
punctuated by the aforementioned paroxysms (precipitated by
emotional stress, exercise, changes in posture, and palpation in the
region of the tumor)
• Two thirds of patients with hypertension demonstrate paroxysmal
episodes (abrupt, precipitous elevation in blood pressure, associated
with tachycardia, palpitations, headache, sweating, tremor, and a
sense of apprehension).
• Associated with pain in the abdomen or chest, nausea, and vomiting.
26. GROSS
Small to large hemorrhagic masses
Circumscribed lesions confined to the adrenal
Weighing kilograms.
Average weight of a pheochromocytoma is 100 gm
(weights from 1 gm to 4000 gm).
Larger tumors are well demarcated by either connective
tissue or compressed cortical or medullary tissue.
Richly vascularized fibrous trabeculae within the tumor
produce a lobular pattern.
Remnants of the adrenal gland can be seen, stretched
over the surface or attached at one pole.
Cut surfaces
Smaller are yellow-tan.
Larger lesions tend to be hemorrhagic, necrotic & cystic
and efface the adrenal gland.
Incubation of fresh tissue with a potassium dichromate
solution turns the tumor a dark brown color due to
oxidation of stored catecholamines.
27. MICROSCOPY
• Composed of clusters of polygonal
to spindle- shaped chromaffin cells
or chief cells
• Surrounded by supporting
sustentacular cells, creating small
nests or alveoli (zellballen) that are
supplied by a rich vascular network .
• Cytoplasm has a finely granular
appearance, best demonstrated
with silver stains, due to the
presence of granules containing
catecholamines.
• Nuclei are usually round to ovoid,
with a stippled “salt and pepper”
chromatin that is characteristic of
neuroendocrine tumors.
29. IMMUNOHISTOCHEMISTRY
• Chromogranin and
synaptophysin is seen in the
chief cells.
• Peripheral sustentacular cells
stain with antibodies against S-
100, a calcium-binding protein
expressed by a variety of
mesenchymal cell types.
S100 Staining
30. • There is no histologic feature that reliably predicts clinical behavior.
• The definitive diagnosis of malignancy in pheochromocytomas is
based exclusively on the presence of metastases.
• Sites of metastasis: Regional lymph nodes, liver, lung, and bone.
31. COMPLICATIONS
• The elevations of blood pressure are induced by the sudden release of
catecholamines may lead to:
Congestive heart failure
Pulmonary edema
Myocardial infarction
Ventricular fibrillation
Cerebrovascular accidents.
• Cardiac complications called catecholamine cardiomyopathy, or
catecholamine-induced myocardial instability
32. LAB DIAGNOSIS
• Based on the demonstration of increased urinary excretion of free
catecholamines and their metabolites, such as vanillylmandelic acid
and metanephrines.
33. TREATMENT
• Isolated benign tumors are treated with surgical excision.
• After preoperative and intraoperative medication of patients with
adrenergic-blocking agents to prevent a hypertensive crisis.
• Multifocal lesions require long-term medical treatment for
hypertension.
34. NEUROBLATIC TUMORS
• The term neuroblastic tumor includes tumors of the sympathetic ganglia and
adrenal medulla that are derived from primordial neural crest cells populating
these sites.
• Neuroblastoma is the most important member of this family.
• Most common extracranial solid tumor of childhood.
• Most frequently (40%) diagnosed tumor of infancy.
• Prevalence is about one case in 7000 live births.
• Median age at diagnosis is 18 months.
35. • Most occur sporadically
• 1% to 2% are familial and may involve both of the adrenals or
multiple primary autonomic sites.
• Germline mutations in the anaplastic lymphoma kinase (ALK)
gene is identified as a major cause of familial predisposition
to neuroblastoma.
• Somatic gain-of-function ALK mutations are observed in less
than 10% of sporadic neuroblastomas.
36. • Sites of occurence:
• Adrenal medulla(40%).
• Paravertebral region of the abdomen (25%) and
• Posterior mediastinum (15%).
• Pelvis, the neck, and within the brain (cerebral neuroblastomas).
In situ neuroblastomas are reported to occur 40 times more
frequently than clinically overt tumors.
37. CLINICAL FEATURES
• Under age 2 years: large abdominal masses, fever, and weight loss.
• In older children, metastases produce manifestations, such as bone pain, respiratory symptoms,
or gastrointestinal complaints.
• Proptosis
• Ecchymosis due to spread to the periorbital region, a common metastatic site.
• Bladder and bowel dysfunction (due to paraspinal neuroblastomas that impinge on nerves).
• In neonates, multiple cutaneous metastases (disseminated neuroblastomas) that cause deep blue
discoloration of the skin ( “blueberry muffin baby”).
38. Pheochromocytoma Neuroblastoma
Produce catecholamines. 90% of neuroblastomas produce
catecholamines.
Elevated blood levels of
catecholamines and elevated urine
levels of the metabolites
vanillylmandelic acid [VMA] and
homovanillic acid [HVA])
Elevated blood levels of
catecholamines and elevated urine
levels of the metabolites
vanillylmandelic acid [VMA] and
homovanillic acid [HVA])
Hypertension is more common Hypertension is less common
39. GROSS
Minute nodules (so-called in situ
lesions) to large masses
More than 1 kg in weight.
Often sharply demarcated by a
fibrous pseudo-capsule
Some are infiltrative and invade
surrounding structures, including the
kidneys, renal vein, and vena cava,
and envelop the aorta.
Cut surface:
Soft, gray-tan
Larger tumors have areas of necrosis,
cystic softening, and hemorrhage.
Occasionally, foci of punctate intra-
tumoral calcification seen
40. MICROSCOPY
• composed of small, primitive-
appearing cells with dark nuclei,
scant cytoplasm, and poorly defined
cell borders growing in solid sheets.
• Mitotic activity, nuclear breakdown
(“karyorrhexis”) and pleomorphism
may be prominent.
• Background demonstrates a faintly
eosinophilic fibrillary material
(neuropil) which are neuritic
processes of the primitive
neuroblasts.
• Homer- Wright pseudorosettes
(tumor cells are concentrically
arranged about a central space filled
with neuropil )
41. ELECTRON MICROSCOPY
• small, membrane-bound,
cytoplasmic
catecholamine-containing
secretory granules
• the latter contain
characteristic central
dense cores surrounded
by a peripheral halo
(dense core granules).
Synaptic vesicle in a neuroblastoma cell. These vesicles are larger
and more irregular than the normal presynaptic terminals.
Numerous dense core neurosecretory granules are present.
43. • Metastases appear early and widely.
• Local infiltration and lymph node spread
• Hematogenous & lymphatic spread to liver, lungs, bone marrow, and
bones.
44. The International Neuroblastoma Staging
System
• Stage 1: Localized tumor with complete gross excision, with or without
microscopic residual disease; representative ipsilateral nonadherent
lymph nodes negative for tumor (nodes adherent to the primary tumor
may be positive for tumor).
• Stage 2A: Localized tumor with incomplete gross resection;
representative ipsilateral nonadherent lymph nodes negative for tumor
microscopically.
• Stage 2B: Localized tumor with or without complete gross excision;
ipsilateral nonadherent lymph nodes positive for tumor; enlarged
contralateral lymph nodes, which are nega- tive for tumor
microscopically.
45. • Stage 3: Unresectable unilateral tumor infiltrating across the midline
with or without regional lymph node involvement; or localized
unilateral tumor with contralateral regional lymph node involvement.
• Stage 4: Any primary tumor with dissemination to distant lymph
nodes, bone, bone marrow, liver, skin, and/or other organs (except as
defined for stage 4S).
• Stage 4S (“S” = special): Localized primary tumor (as defined for
stages 1, 2A, or 2B) with dissemination limited to skin, liver, and/or
bone marrow; stage 4S is limited to infants younger than 1 year.
46. PROGNOSTIC FACTORS:
based on the collection
of prognostic factors,
classified either as low,
intermediate or high
risk.
47. Ganglioneuroma
• Better differentiated lesions
• Containing many more large cells resembling mature ganglion cells
• Presence of few residual neuroblasts.
• Either asymptomatic mass lesions or symptoms related to
compression.
48. Ganglioneuroblastoma
• Larger cells having more abundant cytoplasm, large vesicular nuclei, and a
prominent nucleolus, representing ganglion cells in various stages of
maturation admixed with primitive neuroblasts.
• Maturation of neuroblasts into ganglion cells is usually accompanied by the
appearance of Schwann cells.
• Presence of schwannian stroma composed of organized fascicles of neuritic
processes, mature Schwann cells, and fibroblasts is a histologic prerequisite
for the designation of ganglioneuroblastoma and ganglioneuroma.
50. LAB DIAGNOSIS
• Screening for asymptomatic tumors in children.
• Based on the demonstration of increased urinary excretion of free
catecholamines and their metabolites, such as vanillylmandelic acid
and homovanillic acid.
51. TREATMENT
• Use of retinoids as an adjunct therapy for inducing the differentiation
of neuroblastoma.
• Targeted inhibitors ALK and such agents are currently undergoing
evaluation in clinical trials.
53. Myelolipoma
• Unsual benign tumor
• Composed of mature fat and hematopoietic cells.
• Incidental findings
• Foci of myelolipomatous change may be seen in cortical tumors and in adrenals
with cortical hyperplasia.
• Occasional myelolipomas may reach massive proportions.
55. Adrenal incidentaloma
• Incidental discovery.
• Asymptomatic individuals.
• In individuals in whom the presenting complaint is not directly related
to the adrenal gland.
• Estimated population prevalence of “incidentalomas” discovered by
imaging is approximately 4%,
• Age-dependent increase in prevalence.
• Majority are small nonsecreting cortical adenomas of no clinical
importance.
Editor's Notes
#2:The two components of adrenal gland are : adrenal cortex on the outer side and inner adrenal medulla.
The adrenal cortex consists of three histological zones namely (from outside to inside )
#3:Pituitary releases acth which acts on adrenal cortex to release the following hormones
#12:adenomas are homogenous and well-delineated cortical neoplasms that are enriched in lipid-rich adrenal cortical cells resulting in a yellow color
#14:Adenomas have cords, nests and islands of lipid rich clear cells and lipid poor compact cells in varying proportions.